The results showed that both LC3B‐II and p62 were increased in a dose‐dependent manner (Fig. 1A) and reached a maximum at 24 h after treatment of 500 μg·mL−1 of PG in both GBM cells (Fig. 1B). The gene discussed is SQSTM1; the disease is glioblastoma.